Terminated PHASE3 INTERVENTIONAL 2-arm NCT03637335

Comparing Palliative Radiotherapy With or Without Carboplatin (METAXIOM)

Phase-3 Study, Randomized, Controlled, Multi-center, Double Blind, Comparing Palliative Radiotherapy With or Without Carboplatin

Sponsor: Institut Cancerologie de l'Ouest

Conditions Head and Neck Cancer Lung Cancer Metastatic Cancer

Interventions irradiation + carboplatin irradiation + placebo

Updated 4 times since 2018 Last updated: Aug 16, 2018 Started: Aug 17, 2015 Primary completion: Nov 28, 2017 Completion: May 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was stopped due to insufficient recruitment.

Other terminated trials from Institut Cancerologie de l'Ouest

See all terminations from Institut Cancerologie de l'Ouest

Other Head and Neck Cancer trials with similar outcome

Browse all Head and Neck Cancer trials

This PHASE3 trial investigates Head and Neck Cancer and Lung Cancer and is currently terminated or withdrawn. Institut Cancerologie de l'Ouest leads this study, which shows 4 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Sep 2018 — Jan 2021 [monthly]

Terminated PHASE3

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Cancerologie de l'Ouest

Data source: Institut Cancerologie de l'Ouest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Le Mans, France
• Nantes, France